A carregar...
BET bromodomain inhibitors—A novel epigenetic approach in castration-resistant prostate cancer
The androgen receptor (AR) is central to the initiation and progression of prostate cancer, even after castration. There has been some success in therapies targeting AR signaling which have been shown to extend survival in men with castration-resistant prostate cancer (CRPC). However, durable respon...
Na minha lista:
| Publicado no: | Cancer Biol Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622075/ https://ncbi.nlm.nih.gov/pubmed/25535892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/15384047.2014.962297 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|